From practical clinical features to warnings and TGA decisions, 2024 had it all.
As 2024 comes to a close, it’s time to reflect on the Oncology Republic stories from the year that our readers loved the most.
Practical clinical features were a hit, along with news about research, CAR T therapy and clinical trials.
See the top 10 most read Oncology Republic stories for 2014 below:
- What’s ‘vaper’s tongue’ and why does it happen? by Helen Tobler: Vapes and e-cigarettes can accelerate oral disease and many of the damaging effects are irreversible, experts warn. Young people were presenting with damage from vapes that normally occurs in older tobacco smokers, said Melbourne dentist Dr Dilhan Rajasingham.
- Our top 30 most valuable healthtech companies, by Jeremy Knibbs: As the headline suggests, a deep dive into our healthtech companies, by Oncology Republic publisher Jeremy Knibbs.
- Public funding for CAR T therapy Tecartus, by Mariella Attard: CAR T Cell therapy Tecartus (brexucabtagene autoleucel, Gilead) became publicly funded for patients with mantle cell lymphoma (a rare subtype of non-Hodgkin lymphoma) who have relapsed or are refractory (r/r MCL) to at least two or more lines of therapy.
- Cryoablation for renal cancer: a safe and effective alternative to surgery, by Dr Will Ormiston: This clinical feature examined the use of cryoablation, which provides the ability to treat larger tumours and perform more technically challenging procedures when compared to older technology, such as radiofrequency (RFA) or microwave ablation (MWA), due to the more gentle effects on the kidney and collecting system and the visibility of the ablation zone, unlike other modalities.
- Car T cell therapy progress in glioblastoma, by Mariella Attard: Car T cell treatment targeting EGFR III reduced tumour size for three patients with glioblastoma in a first-in-humans trial, according to interim findings published in the NEJM.
- GenesisCare out the other side of bankruptcy, by OR staff: GenesisCare, one of the world’s largest providers of cancer services and the largest provider of radiation oncology services in Australia, completed the restructure required by the Texas Bankruptcy Court.
- Public precision medicine clinic opens in Sydney, by Mariella Attard: The Precision Care Clinic at the Prince of Wales Hospital in Sydney’s eastern suburbs will use individual molecular and genetic data and the latest research to personalise cancer management plan recommendations, including targeted therapies, clinical trials and risk management for people with complex cancers.
- Progestogens link to meningioma risk identified, by Helen Tobler: French researchers have identified three new progestogens as increasing the risk of intracranial meningioma, according to their study published in the BMJ.
- Tumour-killing viruses not just pie in the sky, by Laura Andronicos: A tumour-attacking virus has achieved elimination of tumours in 64% of patients with bladder cancer who were unresponsive to conventional treatment, according to interim findings presented at the 24th Annual Meeting of the Society of Urologic Oncology (SUO) in Washington.
- What’s in and out of the health budget? by Cate Swannell: A clinical trial one-stop-shop and changes to the national bowel screening program are a couple of the cancer spending headlines delivered by the federal government’s budget in May.
We wish all our readers happy and safe holidays, and we look forward to your company in 2025. As always feel free to reach out with any ideas for stories or comments to amanda@medicalrepublic.com.au
